v3.24.2.u1
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 03, 2024
Jun. 30, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2021
Dec. 31, 2023
Stock-Based Compensation (Details) [Line Items]                
Issuance of common stock   2,367,601 0   13,776,419 133,922    
Unrecognized compensation cost related to nonvested stock options grant (in Dollars)   $ 3,600     $ 3,600      
Weighted-average over period         1 year 1 month 6 days      
Long-term liability   $ 386,910     $ 386,910     $ 381,436
Third anniversary [Member]                
Stock-Based Compensation (Details) [Line Items]                
Share prices of our common stock   $ 24.2     $ 24.2      
Performance Based Restricted Stock Units [Member]                
Stock-Based Compensation (Details) [Line Items]                
Vesting description         the vesting dates, which we anticipate will be in March 2025, February 2026 and April 2027, for awards granted in 2022, 2023 and 2024, respectively. Our performance did not meet the required conditions for vesting for the PRSUs that were scheduled to vest in February 2024 and accordingly they expired unvested during the six months ended June 30, 2024. We are currently assuming 100% attainment of our 2026 and 2025 metrics and 0% attainment of our 2024 metrics. All of the PRSUs granted in 2022, 2023 and 2024 remained outstanding at June 30, 2024.      
Restricted stock shares outstanding   824,698     824,698      
Recognized related compensation expense   $ 0     $ 0      
Performance Based Restricted Stock Units [Member] | Maximum [Member]                
Stock-Based Compensation (Details) [Line Items]                
Vesting percentage         100.00%      
Performance Based Restricted Stock Units [Member] | Minimum [Member]                
Stock-Based Compensation (Details) [Line Items]                
Vesting percentage         50.00%      
Stock Appreciation Rights [Member]                
Stock-Based Compensation (Details) [Line Items]                
Share-based compensation, authorized shares 1,732,854              
Weighted Average Exercise Price, Granted (in Dollars per share) $ 1.06              
Grant date fair value of stock granted $ 0.61              
Stock Option                
Stock-Based Compensation (Details) [Line Items]                
Weighted average grant-date fair value of options granted (in Dollars per share)       $ 1.17        
Number of Shares, Granted   0   204,254 0      
Long-term liability               100
Market Based Restricted Shares [Member]                
Stock-Based Compensation (Details) [Line Items]                
Restricted stock shares   754,818     754,818      
Number of Shares, Granted         1,517,840   1,517,840  
Liability   $ 300     $ 300     $ 300
Market Based Restricted Shares [Member] | Maximum [Member]                
Stock-Based Compensation (Details) [Line Items]                
Stock-based compensation expense   $ 200 $ 200   $ 100 $ 400    
Cash Settled Options [Member]                
Stock-Based Compensation (Details) [Line Items]                
Number of Shares, Granted       1,050,000        
2020 ESPP [Member]                
Stock-Based Compensation (Details) [Line Items]                
Issuance of common stock         136,530      
Shares issued from inception   401,748     401,748      
ESPP plan, percentage of stock discount         15.00%      
Share-based compensation, authorized shares   2,571,737     2,571,737      
2020 Incentive Plan [Member]                
Stock-Based Compensation (Details) [Line Items]                
Share-based compensation, remained authorized for Issuance   1,831,616     1,831,616     4,823,519